Q5107 Injection mvasi 10 milligrams
Also known as: Mvasi injection, bevacizumab-awwb
Injection of Mvasi, bevacizumab-awwb biosimilar per 10 milligrams, a vascular endothelial growth factor inhibitor.
In Plain Language
cancer-fighting biologic; tumor growth blocker
Clinical Context
Used for metastatic colorectal, breast, lung, and ovarian cancers to inhibit tumor angiogenesis.
RVU Information
CPT Q5107 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5107?
CPT Q5107 (Injection mvasi 10 milligrams) is a Q Codes code. Injection of Mvasi, bevacizumab-awwb biosimilar per 10 milligrams, a vascular endothelial growth factor inhibitor.
Is Q5107 covered by insurance?
Q5107 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for metastatic colorectal, breast, lung, and ovarian cancers to inhibit tumor angiogenesis.
When is CPT Q5107 used?
Used for metastatic colorectal, breast, lung, and ovarian cancers to inhibit tumor angiogenesis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.